Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic inflammation, but the connection is murky.

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

Empower Pharmacy could be banned from doing business in California after the state's pharmacy board moved to revoke Empower's probation in November, records show.

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

Weight loss drugs have been linked to lowering the risk of many serious conditions, including dementia. Now, experts are ...

Dietary supplements, as benign as they may seem, when mixed with drugs and other supplements, can lead to unintended consequences. Certain supplements can aggravate existing medical conditions and ...

The drug is still in the trial phase.

The route a drug takes into the body can matter as much as the drug itself – and rectal use brings risks that are rarely talked about openly. In health settings, this route is familiar through ...

Common supplements like melatonin and magnesium can interact with your prescription drugs. Learn which sleep aids to avoid to stay healthy.

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.